RICH
MCID: RPD005
MIFTS: 39

Rapidly Involuting Congenital Hemangioma (RICH)

Categories: Cardiovascular diseases, Fetal diseases, Rare diseases

Aliases & Classifications for Rapidly Involuting Congenital Hemangioma

MalaCards integrated aliases for Rapidly Involuting Congenital Hemangioma:

Name: Rapidly Involuting Congenital Hemangioma 58
Rich 58

Characteristics:

Orphanet epidemiological data:

58
rapidly involuting congenital hemangioma
Inheritance: Not applicable; Age of onset: Infancy,Neonatal;

Classifications:

Orphanet: 58  
Rare circulatory system diseases
Developmental anomalies during embryogenesis


External Ids:

ICD10 via Orphanet 33 D18.0
UMLS via Orphanet 72 C1275421
Orphanet 58 ORPHA141184

Summaries for Rapidly Involuting Congenital Hemangioma

MalaCards based summary : Rapidly Involuting Congenital Hemangioma, also known as rich, is related to hemangioma and congenital hemangioma. The drugs Insulin aspart and Parathyroid hormone have been mentioned in the context of this disorder. Affiliated tissues include bone, liver and skin, and related phenotypes are telangiectasia of the skin and subcutaneous calcification

Wikipedia : 74 A vascular tumor is a tumor of vascular origin; a soft tissue growth that can be either benign or... more...

Related Diseases for Rapidly Involuting Congenital Hemangioma

Diseases related to Rapidly Involuting Congenital Hemangioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 18)
# Related Disease Score Top Affiliating Genes
1 hemangioma 10.8
2 congenital hemangioma 10.8
3 non-involuting congenital hemangioma 10.5
4 arteriovenous malformation 10.2
5 thrombocytopenia 10.2
6 posttransplant acute limbic encephalitis 10.2
7 rare tumor 10.2
8 angioma, tufted 10.1
9 deficiency anemia 10.1
10 telangiectasis 10.1
11 vascular cancer 10.1
12 teratoma 10.1
13 fibrosarcoma 10.1
14 congenital fibrosarcoma 10.1
15 cleft lip 10.1
16 hemangioendothelioma 10.1
17 kaposiform hemangioendothelioma 10.1
18 rare vascular tumor 10.1

Graphical network of the top 20 diseases related to Rapidly Involuting Congenital Hemangioma:



Diseases related to Rapidly Involuting Congenital Hemangioma

Symptoms & Phenotypes for Rapidly Involuting Congenital Hemangioma

Human phenotypes related to Rapidly Involuting Congenital Hemangioma:

58 31 (show all 15)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 telangiectasia of the skin 58 31 frequent (33%) Frequent (79-30%) HP:0100585
2 subcutaneous calcification 58 31 frequent (33%) Frequent (79-30%) HP:0007618
3 midfrontal capillary hemangioma 58 31 frequent (33%) Frequent (79-30%) HP:0007466
4 perineal hemangioma 58 31 frequent (33%) Frequent (79-30%) HP:0031449
5 congestive heart failure 58 31 occasional (7.5%) Occasional (29-5%) HP:0001635
6 thrombocytopenia 58 31 occasional (7.5%) Occasional (29-5%) HP:0001873
7 peripheral arteriovenous fistula 58 31 occasional (7.5%) Occasional (29-5%) HP:0100784
8 prominent superficial veins 58 31 occasional (7.5%) Occasional (29-5%) HP:0001015
9 lipoatrophy 58 31 very rare (1%) Very rare (<4-1%) HP:0100578
10 hepatic hemangioma 58 31 very rare (1%) Very rare (<4-1%) HP:0031207
11 avascular necrosis 31 very rare (1%) HP:0010885
12 aseptic necrosis 58 Very rare (<4-1%)
13 hemangioma 58 Obligate (100%)
14 visceral hemangioma 58 Occasional (29-5%)
15 tufted angioma 58 Excluded (0%)

Drugs & Therapeutics for Rapidly Involuting Congenital Hemangioma

Drugs for Rapidly Involuting Congenital Hemangioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 957)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Insulin aspart Approved Phase 4 116094-23-6 16132418
2
Parathyroid hormone Approved, Investigational Phase 4 9002-64-6
3
Asenapine Approved Phase 4 65576-45-6, 85650-56-2 3001386
4
Lactulose Approved Phase 4 4618-18-2 11333
5
Insulin lispro Approved Phase 4 133107-64-9
6
Insulin glulisine Approved Phase 4 207748-29-6
7
Linagliptin Approved Phase 4 668270-12-0 10096344
8
Cimetidine Approved, Investigational Phase 4 51481-61-9 2756
9
leucovorin Approved Phase 4 58-05-9 6006 143
10
Nicotinamide Approved, Investigational Phase 4 98-92-0 936
11
Simvastatin Approved Phase 4 79902-63-9 54454
12
Iron Approved, Experimental Phase 4 7439-89-6, 15438-31-0 23925 27284
13
Magnesium citrate Approved Phase 4 3344-18-1
14
Potassium citrate Approved, Investigational, Vet_approved Phase 4
15
Primaquine Approved Phase 4 90-34-6 4908
16
Artesunate Approved, Investigational Phase 4 88495-63-0 5464098 6917864
17
Dimenhydrinate Approved Phase 4 523-87-5 441281
18 Artichoke Approved Phase 4
19
Ezetimibe Approved Phase 4 163222-33-1 150311
20
Metronidazole Approved Phase 4 443-48-1 4173
21
Palonosetron Approved, Investigational Phase 4 119904-90-4, 135729-61-2, 135729-56-5 148211
22
Flurbiprofen Approved, Investigational Phase 4 5104-49-4 3394
23
Pentazocine Approved, Vet_approved Phase 4 359-83-1 441278
24
Vildagliptin Approved, Investigational Phase 4 274901-16-5 6918537
25
Lixisenatide Approved Phase 4 320367-13-3
26
Ciprofloxacin Approved, Investigational Phase 4 85721-33-1 2764
27
Allopurinol Approved Phase 4 315-30-0 2094
28
Histamine Approved, Investigational Phase 4 51-45-6 774
29
Amodiaquine Approved, Investigational Phase 4 86-42-0 2165
30
Ribavirin Approved Phase 4 36791-04-5 37542
31
Peginterferon alfa-2b Approved Phase 4 99210-65-8, 215647-85-1
32
Polymyxin B Approved, Vet_approved Phase 4 1404-26-8
33
Neomycin Approved, Vet_approved Phase 4 1404-04-2 8378
34
Bacitracin Approved, Vet_approved Phase 4 1405-87-4 439542 10909430
35
Ferrous succinate Approved Phase 4 10030-90-7
36
Glimepiride Approved Phase 4 93479-97-1 3476
37
Xylometazoline Approved, Investigational Phase 4 526-36-3 5709
38
Cilostazol Approved, Investigational Phase 4 73963-72-1 2754
39
Pyrimethamine Approved, Investigational, Vet_approved Phase 4 58-14-0 4993
40
Sulfadoxine Approved, Investigational Phase 4 2447-57-6 17134
41
Hyaluronic acid Approved, Vet_approved Phase 4 9004-61-9 53477741
42
Atorvastatin Approved Phase 4 134523-00-5 60823
43
Sargramostim Approved, Investigational Phase 4 83869-56-1, 123774-72-1
44
Lenograstim Approved, Investigational Phase 4 135968-09-1
45
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
46
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
47
Mannitol Approved, Investigational Phase 4 69-65-8 453 6251
48
Guaifenesin Approved, Investigational, Vet_approved Phase 4 93-14-1 3516
49
Probucol Approved, Investigational Phase 4 23288-49-5 4912
50
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821

Interventional clinical trials:

(show top 50) (show all 2886)
# Name Status NCT ID Phase Drugs
1 Efficacy of Intra-articular Injection of Combined Hyaluronic Acid and Platelet-rich Plasma in Knee Degenerative Joint Disease Unknown status NCT03211650 Phase 4 hyaluronic Acid + platelet-rich plasma;hyaluronic acid;platelet-rich plasma
2 Evaluation of Platelet Rich Fibrin Efficacy on Reduction of Periodontal Problems Unknown status NCT01583491 Phase 4
3 The Effect of Using Autologous Platelet Rich Plasma on Posterior Lumbar Interbody Fusion : a Randomized Comparative Trial Unknown status NCT03261843 Phase 4
4 Evaluating the Efficacy of Different Platelet Rich Plasma (PRP) Treatment Regimens in the Management of Androgenetic Alopecia: an Investigator-initiated, Single-center, Single-blinded, Prospective, Randomized Clinical Trial Unknown status NCT02999737 Phase 4
5 A 104-week, Open-label, Single-group Study: Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH) Unknown status NCT00885872 Phase 4 Rosuvastatin (Crestor)
6 Platelet Rich Fibrin in the Treatment of Palatal Wounds After Epithelialized Free Gingival Grafts Harvesting. A Randomized Clinical Trial Unknown status NCT02438046 Phase 4
7 Does Varying the Chloride Content of Intravenous Fluid Alter the Risk of Acute Kidney Injury After Cardiac Surgery? Unknown status NCT02020538 Phase 4
8 Omega-3 Fatty Acids in First-episode Schizophrenia - a Randomized Controlled Study of Efficacy and Relapse Prevention (OFFER). Rationale, Design, and Methods. Unknown status NCT02210962 Phase 4
9 Low Dose Calcium Supplementation to Prevent Preeclampsia: a Cluster Randomized Study Unknown status NCT02338687 Phase 4
10 An Open-label Switch Study to Asenapine in the Early Stage of Psychosis Unknown status NCT01968161 Phase 4 Asenapine
11 Comparative Study About the Impact of Two Oil Emulsions, One of Them Formulated With MCT, LCT, Olive Oil and Omega 3 Fatty Acids Versus Another One Formulated With MCT and LCT, Administered Intravenously on Severe Acute Pancreatitis Clinical Evolution Unknown status NCT01376817 Phase 4 Fat emulsion with MCT, LCT, olive oil and omega 3 fatty acids;Fat emulsion with MCT and LCT
12 Randomized Clinical Trial of Omega-3 Fatty Acid-supplemented Parenteral Nutrition Versus Standard Parenteral Nutrition in Patients Undergoing Major Laparoscopic Abdominal Surgery Unknown status NCT01819961 Phase 4 MCT/LCT and fish oil;MCT/LCT
13 Adjusted Steroid Therapy in Children With Idiopathic Nephrotic Syndrome Unknown status NCT02649413 Phase 4 Prednisone
14 Effect of Multi-vitamins With Minerals on Uric Acid Metabolism in Subjects With Hyperuricemia: A Randomized, Double-blinded, Placebo-controlled Trail Unknown status NCT03218709 Phase 4
15 Delayed Vasospasm After Aneurysm With the Standardization Treatment of Traditional Chinese Medicine Unknown status NCT01840761 Phase 4 herbal drug;placebo
16 Treatment of Plantar Fasciitis With Injection af Platelet-rich Plasma Into the Origin of the Plantar Fascia - a Prospective, Randomized and Double Blinded Study. Unknown status NCT01509274 Phase 4
17 Insulin Requirement for Pure- Protein Meal in Children With Type 1 Diabetes Treated With Continuous Subcutaneous Insulin Infusion - a Cross-over, Randomized Trial. Unknown status NCT02685449 Phase 4 Insulin glulisine;Insulin aspart;Insulin lispro
18 Phase 4 Study of Vitamin D3 Supplementation for Outcomes in Patients With Unipolar Depression Unknown status NCT01390662 Phase 4
19 Effect of Linagliptin on Intestinal Triglyceride-rich-lipoprotein Metabolism in Type 2 Diabetic Patients Unknown status NCT02280174 Phase 4 linagliptin
20 Prostatic Artery Embolization Versus 532 nm Green Light Laser Photoselective Vaporization of the Prostate for Treating Catheter-Dependent Patients With Benign Prostatic Hyperplasia: A Randomized Controlled Clinical Study Unknown status NCT02006303 Phase 4
21 Effects of a Chronical Treatment With Benfotiamine in People With Type 2 Diabetes Mellitus on Pre- and Postprandial Endothelial Function, as Well as on the Function of the Autonomic Nervous System Unknown status NCT00446810 Phase 4 Benfotiamine;Placebo
22 Pre-hYpertension tReament With A coMbinatIon of Dietary Supplements and Life-style Modifications Unknown status NCT01682291 Phase 4
23 Effect of Rosuvastatin Therapy on HDL2 Level and Antiatherosclerotic Reverse Cholesterol Transport Process in Chinses CAD Patients With Hyperlipidemia Unknown status NCT02593487 Phase 4 Rosuvastatin 10mg/d group;Rosuvastatin 20mg/d group
24 Artemether/ Lumefantrine: A Study of the Effect of Local Food on Pharmacokinetics of Lumefantrine and Population Pharmacokinetics of Lumefantrine Among Ugandan Children Unknown status NCT01944189 Phase 4
25 Effect of Iron Supplementation on Psychomotor Development of Non-anemic Exclusively or Predominantly Breastfed Infants: Randomized, Double-blind, Placebo-controlled Trial. Unknown status NCT02242188 Phase 4 Iron
26 Multicenter Study Evaluating the Efficacy of Dicopeg Junior in Comparison With Lactulose for the Treatment of Functional Constipation in Children Aged 6 Months to 6 Years. A Prospective, Randomized Study. Unknown status NCT03177434 Phase 4 polyethylene glycols (PEG) 3350;Lactulose Oral Product
27 Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome Unknown status NCT01951001 Phase 4 Prasugrel
28 A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF THE SUPPLEMENTATION WITH KIOLIC® IN PATIENTS WITH DIAGNOSIS OF METABOLIC SYNDROME TO IMPROVE ENDOTHELIAL FUNCTION AND INFLAMMATORY STATE. "KYMES" Unknown status NCT01168700 Phase 4 aged garlic extract;Placebo
29 The ACT-OUT Trial: ACTivity OUTcomes Based on the Consumption of a High Carbohydrate or High Fat Diet in Patients With Metabolic Syndrome Unknown status NCT01357382 Phase 4
30 Effect of Platelet Rich Plasma ( PRP ) Applied During Knee Arthroscopy on Pain, Function and Quality of Life - A RCT With a Follow up of 12 Months Completed NCT02189408 Phase 4
31 Platelet Rich Plasma (PRP) in Total Knee Replacement: A Prospective, Randomized, Single-blind, Single-center Clinical Study to Evaluate the Effect of Platelet Rich Plasma (PRP) on Short-term Patient Outcomes Following Total Knee Replacement Completed NCT00826098 Phase 4
32 A Prospective Study to Analyze the Efficacy of IgM Rich Immunoglobulin as an Adjunct to Antibiotics in the Treatment of Bacterial Sepsis in Very Low Birth Weight Preterm Neonates Completed NCT03403530 Phase 4 IgM rich Immunoglobin
33 Impact of Short-term Fructose-enriched Diet on Serum Metabolome by Normal- and Over-weighed Women. Completed NCT03444233 Phase 4
34 Socket Augmentation Using Different Platelet Concentrates, Atorvastatin Gel or Combination (Clinical and Histomorphometric Study) Completed NCT03231137 Phase 4 ATV gel
35 Intra-Articular Use of Platelet Rich Plasma Versus Corticosteroid: A Clinical Trials in Osteoarthritis of Knee. Completed NCT03086759 Phase 4 Triamcinolone Hexacetonide
36 Adjunctive Role of Platelets Rich Fibrin in Palatal Wound Healing After Free Gingival Graft Harvesting - Case Series Completed NCT02521467 Phase 4
37 The Effect of Nitrate Supplementation: Source of Supplementation Completed NCT02271633 Phase 4
38 Arthroscopic Rotator Cuff Repair Using Standard Double Row Technique With Platelet Rich Fibrin Membrane vs. Standard Double Row Technique: A Randomized Blinded Outcomes Study Completed NCT02256891 Phase 4
39 A Cohort Study to Evaluate the Effect of Vivostat Platelet Rich Fibrin on Diabetic Foot Ulcers. Completed NCT00770939 Phase 4
40 Regeneration of the Patellar Tendon After Harvesting Its Central Third With Platelet-rich Plasma. Prospective and Randomized Study. Completed NCT01111747 Phase 4
41 Pilot Study: Randomized Controlled Trial on the Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors Completed NCT00168987 Phase 4 oral nutritional supplement rich in eicosapentanoic acid
42 The Comparison of Knee Osteoarthritis Treatment With Single-dose of Bone Marrow Aspirate Concentrate, Single-dose of Leukocyte Rich Platelet Rich Plasma and 3 Injection of High Molecular Weight Hyaluronic Acid-A Randomized Clinical Trial Completed NCT03825133 Phase 4 Hyaluronic Acid
43 Comparative Study Between Intra Articular Injection of Hyaluronic Acid (HA) With Platelet Rich Plasma (PRP) Versus Genicular Nerve Thermal Radiation in Management of Pain in Knee Osteoarthritis Completed NCT04188561 Phase 4 Intra articular injection Group
44 Socket Augmentation Using Atorvastatin With Or Without PRGF Derived Fibrin Scaffold (Clinical and Histomorphometric Study) Completed NCT03228771 Phase 4 PRGF/ATV;ATV gel
45 Effect of Onion Peel Extract on Endothelial Function and Endothelial Progenitor Cells in Overweight and Obese Subjects Completed NCT02180022 Phase 4 Placebo;Onion peel extract
46 Rosuvastatin 1.2mg in Situ Gel Combined With 1:1 Mixture of Autologous Platelet-rich Fibrin and Porus- Hydroxyappatite Bone Graft in Surgical Treatment of Mandibular Degree II Furcation Defects: A Randomized Clinical Control Trial Completed NCT02369250 Phase 4 Rosuvastatin
47 Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease: Changes in Biomarkers of Oxidative Stress, Profiles of Plasma Amino Acids and Their Derivatives and Brain Function Completed NCT01662414 Phase 4
48 Efficacy and Safety of the Infiltration of Autologous Plasma Rich in Growth Factors (PRGF) in the Symptomatic Treatment of Knee Osteoarthritis Completed NCT00782197 Phase 4
49 Effect of Eicosapentaenoic Acid (EPA) on Major Cardiovascular Events in Hypercholesterolemic Patients: the Japan EPA Lipid Intervention Study (JELIS) Completed NCT00231738 Phase 4 Eicosapentaenoic acid ethyl ester(EPADEL Capsule 300 TM)
50 Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension Completed NCT02653560 Phase 4 Potassium chloride powder;Potassium magnesium Citrate (KMgCit);Potassium citrate powder;Placebo

Search NIH Clinical Center for Rapidly Involuting Congenital Hemangioma

Genetic Tests for Rapidly Involuting Congenital Hemangioma

Anatomical Context for Rapidly Involuting Congenital Hemangioma

MalaCards organs/tissues related to Rapidly Involuting Congenital Hemangioma:

40
Bone, Liver, Skin, Breast, Endothelial, Brain, T Cells

Publications for Rapidly Involuting Congenital Hemangioma

Articles related to Rapidly Involuting Congenital Hemangioma:

(show top 50) (show all 30037)
# Title Authors PMID Year
1
Challenges in CO₂ Reforming with Methane for Production of Hydrogen Rich, Stable Syngas. 61
31748101 2020
2
Vanadate-Rich BiOBr/Bi Nanosheets for Effective Adsorption and Visible-Light-Driven Photodegradation of Rhodamine B. 61
31492236 2020
3
Effect of sinapic acid ester derivatives on the oxidative stability of omega-3 fatty acids rich oil-in-water emulsions. 61
31670124 2020
4
Jabuticaba residues (Myrciaria jaboticaba (Vell.) Berg) are rich sources of valuable compounds with bioactive properties. 61
31704077 2020
5
Telemedicine assessment of long-term cognitive and functional status in anti-leucine-rich, glioma-inactivated 1 encephalitis. 61
31848230 2020
6
Improved osteogenic differentiation of human induced pluripotent stem cells cultured on polyvinylidene fluoride/collagen/platelet-rich plasma composite nanofibers. 61
31250436 2020
7
Lignin-rich sulfated wood nanofibers as high-performing adsorbents for the removal of lead and copper from water. 61
31522065 2020
8
Enhanced polarization of electron-poor/rich micro-centers over nZVCu-Cu(II)-rGO for pollutant removal with H2O2. 61
31541963 2020
9
Nitrogen-rich graphitic carbon nitride nanotubes for photocatalytic hydrogen evolution with simultaneous contaminant degradation. 61
31679783 2020
10
Easy Platelet-Rich Fibrin (Injectable/Topical) for Post-resurfacing and Microneedle Therapy. 61
31779936 2020
11
Structural, rheological and functional properties of galactose-rich pectic polysaccharide fraction from leek. 61
31826450 2020
12
A method to eliminate bromide interference on standard COD test for bromide-rich industrial wastewater. 61
31541900 2020
13
Allogeneic Platelet-Rich Plasma Therapy as an Effective and Safe Adjuvant Method for Chronic Wounds. 61
31622885 2020
14
Protective effects of flavonoid composition rich P. subpeltata Ortega. on indomethacin induced experimental ulcerative colitis in rat models of inflammatory bowel diseases. 61
31669103 2020
15
Anchoring single-unit-cell defect-rich bismuth molybdate layers on ultrathin carbon nitride nanosheet with boosted charge transfer for efficient photocatalytic ciprofloxacin degradation. 61
31706655 2020
16
Metabolic modeling for predicting VFA production from protein-rich substrates by mixed-culture fermentation. 61
31544960 2020
17
Comment on "Platelet-rich plasma and its utility in the treatment of acne scars: A systematic review". 61
31542407 2020
18
Platelet-Rich Plasma and Its Utilities in Alopecia: A Systematic Review. 61
31211715 2020
19
Oxygen vacancy rich Bi2O4-Bi4O7-BiO2-x composites for UV-vis-NIR activated high efficient photocatalytic degradation of bisphenol A. 61
31491668 2020
20
Formation of disinfection byproducts during Fenton's oxidation of chloride-rich landfill leachate. 61
31557577 2020
21
Rainbow trout prefer diets rich in omega-3 long chain polyunsaturated fatty acids DHA and EPA. 61
31647989 2020
22
Postprandial triglyceride-rich lipoproteins promote M1/M2 microglia polarization in a fatty-acid-dependent manner. 61
31707281 2020
23
Biobleaching of mechanical paper pulp using Streptomyces rutgersensis UTMC 2445 isolated from a lignocellulose-rich soil. 61
31609034 2020
24
Anti-inflammation effects of injectable platelet-rich fibrin via macrophages and dendritic cells. 61
31449340 2020
25
Lard-rich and canola oil-rich high-fat diets during pregnancy promote rats' offspring neurodevelopmental delay and behavioral disorders. 61
31676261 2020
26
Selective collection of iron-rich dust particles by natural Trichodesmium colonies. 61
31551530 2020
27
Cacao extract enriched in polyphenols prevents endocrine-metabolic disturbances in a rat model of prediabetes triggered by a sucrose rich diet. 61
31580944 2020
28
The Impact of Metal-Rich Sediments Derived from Mining on Freshwater Stream Life. 61
30671689 2020
29
Involvement of integument-rich CYP4G19 in hydrocarbon biosynthesis and cuticular penetration resistance in Blattella germanica (L.). 61
31149772 2020
30
Recovery of a protein-rich biomass from shrimp (Pandalus borealis) boiling water: A colloidal study. 61
31437710 2020
31
Therapeutic efficacy of arginine-rich exenatide on diabetic neuropathy in rats. 61
31794708 2020
32
Histological Evidence for Therapeutic Induction of Angiogenesis Using Mast Cells and Platelet-Rich Plasma within A Bioengineered Scaffold following Rat Hindlimb Ischemia. 61
31376320 2020
33
Plasma rich in growth factors for the treatment of dry eye from patients with graft versus host diseases. 61
30585084 2020
34
A novel autologous-made matrix using hyaline cartilage chips and platelet-rich growth factors for the treatment of full-thickness cartilage or osteochondral defects: Preliminary results. 61
31835970 2020
35
Tuning a modular system - synthesis and characterisation of a boron-rich s-triazine-based carboxylic acid and amine bearing a galactopyranosyl moiety. 61
31808482 2020
36
Kidney dysfunction induced by a sucrose-rich diet in rat involves mitochondria ROS generation, cardiolipin changes, and the decline of autophagy protein markers. 61
31657248 2020
37
Effect of tomato (Solanum lycopersicum L.) lycopene-rich extract on the kinetics of rancidity and shelf-life of linseed (Linum usitatissimum L.) oil. 61
31404870 2020
38
Emulsification and oxidation stabilities of DAG-rich algae oil-in-water emulsions prepared with the selected emulsifiers. 61
31525263 2020
39
Expression analysis of genes encoding malectin-like domain (MLD)- and leucine-rich repeat (LRR)- containing proteins in Arabidopsis thaliana. 61
31794328 2020
40
Pilot-scale investigation on nutrient removal characteristics of mineral-rich aerobic granular sludge: Identification of uncommon mechanisms. 61
31630019 2020
41
Exome sequencing of family trios from the National Birth Defects Prevention Study: Tapping into a rich resource of genetic and environmental data. 61
31328417 2019
42
The pro-apoptotic effect of a Terpene-rich Annona cherimola leaf extract on leukemic cell lines. 61
31830975 2019
43
Association of Cyr61-cysteine-rich protein 61 and short-term mortality in patients with acute heart failure and coronary heart disease. 61
31660756 2019
44
Antithrombotic activity of flavonoids and polyphenols rich plant species. 61
31639083 2019
45
Arginine- but not alanine-rich carboxy-termini trigger nuclear translocation of mutant keratin 10 in ichthyosis with confetti. 61
31638346 2019
46
Recombination of B- and T-cell epitope-rich loci from Aedes- and Culex-borne flaviviruses shapes Zika virus epidemiology. 61
31837392 2019
47
A red orange and lemon by-products extract rich in anthocyanins inhibits the progression of diabetic nephropathy. 61
31140616 2019
48
Service delivery innovation for hospital emergency management using rich organizational modelling. 61
29706114 2019
49
Lymphocytic ganglionitis leading to megacolon in lymphocyte-rich glioblastoma. 61
31655421 2019
50
The effect of platelet-rich plasma injection in the treatment of androgenetic alopecia. 61
30895745 2019

Variations for Rapidly Involuting Congenital Hemangioma

Expression for Rapidly Involuting Congenital Hemangioma

Search GEO for disease gene expression data for Rapidly Involuting Congenital Hemangioma.

Pathways for Rapidly Involuting Congenital Hemangioma

GO Terms for Rapidly Involuting Congenital Hemangioma

Sources for Rapidly Involuting Congenital Hemangioma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....